Race as an independent predictor of outcome after treatment for localized prostate cancer

Journal of Urology

Volumn 162, Issue 4, 1999, Pages 1331-1336

  Sohayda, Chris J ^a   Kupelian, Patrick A ^a   Altsman, Kimberly A ^a   Klein, Eric A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Prognostic factors; Prostatectomy; Prostatic neoplasms; Race; Radiotherapy

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

AGE; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE;

EID: 0032845907     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68279-1     Document Type: Article

References (17)

1. Harlan, L., Brawley, O., Pommerenke, F., Wali, P. and Kramer, B.: Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J. Clin. Oncol., 13: 93, 1995.
2. Merrill, R. M. and Brawley, O. W.: Prostate cancer incidence and mortality rates among white and black men. Epidemiology, 8: 126, 1997.
3. Pienta, K. J., Demers, R., Hoff, M., Kau, T. Y., Montie, J. E. and Severson, R. K.: Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. Urology, 45: 93, 1995.
4. Asbell, S. O. and Vijayakumar, S.: Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Prostate, 31: 42, 1997.
5. Fowler, J. E., Jr. and Terrell, F.: Survival in blacks and whites after treatment for localized prostate cancer. J. Urol., 156: 133, 1996.
6. Kim, J. A., Kuban, D. A., el-Mahdi, A. M. and Schellhammer, P. F.: Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy. Radiology, 194: 545, 1995.
7. Morgan, T. O., Jacobsen, S. J., McCarthy, W. F., Jacobson, D. J., McLeod, D. G. and Moul, J. W.: Age-specific reference ranges for prostate-specific antigen in black men. New Engl. J. Med., 335: 304, 1996.
8. Morton, R. A., Jr.: Racial differences in adenocarcinoma of the prostate in North American men. Urology, 44: 637, 1994.
9. Moul, J. W., Sesterhenn, I. A., Connelly, R. R. et al.: Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. J.A.M.A., 274: 1277, 1995.
10. Moul, J. W., Douglas, T. H., McCarthy, W. F. and McLeod, D. G.: Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting [see comments]. J. Urol., 155: 1667, 1996.
11. Optenberg, S. A., Thompson, I. M., Friedrichs, P., Wojcik, B., Stein, C. R. and Kramer, B.: Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. J.A.M.A., 274: 1599, 1995.
12. Polednak, A. P.: Stage at diagnosis of prostate cancer in Connecticut by poverty and race. Ethn. Dis., 7: 215, 1997.
13. Ragland, K. E., Selvin, S. and Merrill, D. W.: Black-white differences in stage-specific cancer survival: analysis of seven selected sites. Amer. J. Epidemiol., 133: 672, 1991.
14. Smith, D. S., Bullock, A. D. and Catalona, W. J.: Racial differences in operating characteristics of prostate cancer screening tests. J. Urol., 158: 1861, 1997.
15. Vijayakumar, S., Winter, K., Sause, W., Gallagher, M. J., Michalski, J., Roach, M., Porter, A. and Bondy, M.: Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12. Int. J. Rad. Oncol. Biol. Phys., 40: 17, 1998.
16. Harris, E. and Albert, A.: Survivorship Analysis For Clinical Studies. New York: Marcel Dekker Inc., pp. 5-125, 1991.
17. Cox, D.: Regression models and life-tables. J. Royal Stat. Soc., 34: 187, 1982.